Autoimmune Technologies is a limited liability company with more than thirty "angel investor" LLC members. In addition to the capital contributed by its member partners, the Company's research to date has been supported by U.S. Government grants and contracts totaling approximately $24 million.

Autoimmune Technologies is a member of the Viral Hemorrhagic Fever Consortium. Information about the VHFC can be found at http://vhfc.org/.

The Company fully supports the Research Investigators' Financial Conflict of Interest ("RIFCOI") regulations, “Responsibility of Applicants for Promoting Objectivity in Research for which Public Health Service Funding is Sought” (42 CFR Part 50, Subpart F) and “Responsible Prospective Contractors” (45 CFR Part 94), which apply to some of its work. Autoimmune's RIFCOI Policy is available at this link.